Johnson & Johnson ( JNJ) - Key Metrics
JNJ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $10.38 | $0.09 | $0 | $0 |
| 2026Q2 | ? | ? | ? | ? |
| 2026Q2 | $10.37 | $2.27 | $1.93 | $1.39 |
| 2026Q1 | ? | ? | ? | ? |
| 2026Q1 | $9.84 | $2.14 | $1.03 | $0.60 |
JNJ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 1561.77% | 771.39 |
| 2026Q2 | ? | ? |
| 2026Q2 | 58.31% | 28.47 |
| 2026Q1 | ? | ? |
| 2026Q1 | 59.81% | 28.33 |
JNJ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0% | 0.51% |
| 2026Q2 | ? | ? |
| 2026Q2 | 0.54% | 0.51% |
| 2026Q1 | ? | ? |
| 2026Q1 | 0.25% | 0.53% |
JNJ
List: Champions
Price: $271.22
Dividend Yield: 0.51%
Forward Dividend Yield: 1.98%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 6.59 USD
P/E Ratio: 38.78
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 615.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 4.92%
DGR5: 5.25%
DGR10: 5.71%
DGR20: 7.24%